Technocrats International Journal of Science and Technology

Learning Today,Leading Tomorrow

Submission line is open for Valume-1, Issue-1

About TIJST

Advancing Science, Engineering & Emerging Technologies

Technocrats International Journal of Science and Technology

TIJST is a peer-reviewed, open access international journal committed to publishing high-quality research papers, review articles, and technical notes in science, engineering, and emerging technologies.

The journal provides a global platform for researchers, academicians, industry professionals, and scholars to share innovative ideas, experimental results, and technological advancements.

Research Areas
  • Computer Science & IT
  • Artificial Intelligence & ML
  • Electronics & Communication
  • Mechanical & Civil Engineering
  • Applied Sciences & Mathematics
  • Environmental & Sustainable Tech
  • Biotechnology & Life Sciences
  • Data Science & Cybersecurity

TIJST follows a rigorous double-blind peer review process ensuring quality, originality, and relevance while maintaining the highest ethical standards.

Technocrats International Journal of Science and Technology

Students

Courses

Events

Trainers

Why Choose IJTIJST ?

The Recent Advancements in Engineering, Technology, and Research (IJTIJST) is a premier peer-reviewed journal dedicated to advancing research in pharmacy and pharmaceutical sciences. We offer a platform for publishing high-quality articles across various domains, including pharmacotherapy, clinical pharmacy, pharmaceutical technology, and regulatory affairs.

Global Reach & Fast Publication

Global Reach & Fast Publication IJTIJST ensures quick dissemination of high-quality, peer-reviewed research to a global audience.

Comprehensive Coverage

We publish cutting-edge research across various fields, including pharmacotherapy, clinical pharmacy, and pharmaceutical technology.

Interdisciplinary Impact

Our journal fosters collaboration between pharmacy professionals, researchers, and healthcare providers to enhance patient outcomes.